Monopar Therapeutics
MNPRCIK 0001645469 · last filing Jul 2, 2026
Insider signal
trades dated in the last 90 days · non-derivative only
19,355 bought / 6,900 sold
net +12,455 sh · −$638.9K
- buys
- 3
- sells
- 3
- insiders active
- 3
Filing tape
Filed Thu, Jul 2, 2026
- +721 sh · $46.9K
Vu Quan Anh — Chief Financial Officer
- Exercised1,228Common Stock→ 2,728 held
- Withheld for tax507Common Stock@ $92.59→ 2,221 held
- Exercised1,228Restricted Stock Unit→ 8,598 held
- +8,789 sh · $378.1K
Robinson Chandler — Chief Executive Officer · Director
- Exercised12,873Common Stock→ 103,351 held
- Withheld for tax4,084Common Stock@ $92.59→ 99,267 held
- Exercised12,873Restricted Stock Unit→ 93,403 held
- +2,945 sh · $213.8K
Cittadine Andrew — Chief Operating Officer
- Exercised5,254Common Stock→ 57,923 held
- Withheld for tax2,309Common Stock@ $92.59→ 55,614 held
- Exercised5,254Restricted Stock Unit→ 39,499 held
Insiders on this tape
- Vu Quan AnhChief Financial Officer
- Robinson ChandlerChief Executive Officer · Director
- Cittadine AndrewChief Operating Officer
Informational data only — not investment advice.
The institutional holdings shown here are aggregated from third-party public regulatory filings (such as SEC Form 13F). These filings are reported with a delay (generally up to 45 days after each quarter-end), are backward-looking, and may exclude short positions, non-U.S. holdings, cash, and other assets. The data may contain errors, omissions, misclassifications, or gaps, and may not reflect a manager's current positions.
All figures are provided on an "as is" basis for general information only. Nothing on this page is financial, investment, or trading advice, a recommendation, or an endorsement of any security, manager, or strategy. Do not rely on it. Independently verify any figure against the original filings and consult a qualified professional before making any financial decision. Your use is subject to our Terms of Service.